US$ 24.28
reconstitute tirzepatide 5mg (5mg Vial) Dosage Protocol Tirzepatide - 5mg - Select
Description
Patients treated with GLP-1 medicines had a lower risk of alcohol-related events compared to individuals administered DPP4 inhibitors 54 with greater evidence for benefit during the first 3 months of treatment

Tirzepatide (Mounjaro/Zepbound) : Combines GLP-1 and GIP receptor agonists, offering dual benefits of appetite control and enhanced fat metabolism
To accelerate access, GoodRx and LifeMD are bypassing traditional payer models and launching with a cash-pay strategy

The test identifies your GLP1R rs6923761 and GIPR rs1800437 variants, revealing your genetic likelihood of strong versus mild GLP-1 pathway response

DISCLAIMER The information provided on Care Access is intended for informational purposes only and should not be considered as a substitute for professional medical advice, diagnosis, or treatment

The addition typically adds $20 to $50 per month to the base price
